Admission Date:  [**2104-1-6**]              Discharge Date:   [**2104-1-17**]  Date of Birth:  [**2046-10-17**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**Male First Name (un) 5282**] Chief Complaint: Hematemesis  Major Surgical or Invasive Procedure: EGD  History of Present Illness: 57 yoM w/ HepC cirrhosis w/ known varices EGD [**7-/2103**] presented with one day of coffee-ground and then bright red emesis (<1L); + nausea; no melena/BRBPR.
Baseline Hct in the low to mid-30's.
states that he has been non-adherent w/ diabetic diet on [**3-5**] days PTA.
Recently had Spironolactone dose increased to 100mg qD by PCP.
[**Name10 (NameIs) 17613**] sadness, but no hopelessness, anhedonia or SI.
He was given protonix and ocreotide.
Hepatocellular Carcinoma - two bx lesions c (+) path - s/p RFA [**2103-8-29**] #.
Hep C Genotype 1 - Pegylated interferon, ribavirin ([**2096**]): Viral relapse - Liver bx ([**2099**]): Stage 3 fibrosis, grade 2 inflammation - EGD ([**7-/2101**]): Esophagitis, varices - AFP 9.8 #.
s/p laminectomy ([**11/2095**]) #.
s/p right ankle surgery ([**2089**])  Social History: Lives at home alone in [**Location (un) **], has girlfriend.
Overweight/obesity, DM and HTN in multiple family members.
Physical Exam: VS on arrival to the ED: 118/68, 82, 16, 98% RA VS on arrival to the ICU: 80, 152/75, 13, 100% RA General: comfortable and well nurished appearing HEENT: non-icteric sclera; dry MM Lungs: CTA b/l Cardio: RRR, no m.r.g., no JVD Abd: + BS, soft, NTND Extremities: right leg external rotation > left at rest; Skin: no rashes; WWP Neuro: AA, OX3, no asterixis  By [**2104-1-7**] patient developed loss of attention and prominent asterixis.
Pertinent Results: Labs on admission: [**2104-1-6**] 02:15AM BLOOD WBC-11.7* RBC-2.77* Hgb-8.9* Hct-26.5* MCV-96 MCH-32.3* MCHC-33.8 RDW-14.5 Plt Ct-153 [**2104-1-6**] 11:19AM BLOOD WBC-10.5 RBC-2.61* Hgb-8.4* Hct-23.6* MCV-90 MCH-32.1* MCHC-35.6* RDW-15.8* Plt Ct-117* [**2104-1-7**] 02:54AM BLOOD WBC-13.2* RBC-3.11* Hgb-9.6* Hct-28.7* MCV-92 MCH-31.0 MCHC-33.6 RDW-15.9* Plt Ct-127* [**2104-1-6**] 02:56AM BLOOD PT-18.6* PTT-31.2 INR(PT)-1.7* [**2104-1-7**] 02:54AM BLOOD PT-16.8* PTT-30.2 INR(PT)-1.5* [**2104-1-6**] 02:15AM BLOOD Glucose-257* UreaN-70* Creat-4.3*# Na-124* K-7.1* Cl-89* HCO3-20* AnGap-22* [**2104-1-7**] 02:54AM BLOOD Glucose-61* UreaN-62* Creat-3.2* Na-131* K-4.5 Cl-102 HCO3-22 AnGap-12 [**2104-1-6**] 02:15AM BLOOD ALT-63* AST-151* CK(CPK)-853* AlkPhos-176* TotBili-1.6* [**2104-1-7**] 02:54AM BLOOD ALT-59* AST-120* AlkPhos-147* TotBili-2.2* [**2104-1-6**] 11:19AM BLOOD Calcium-7.4* Phos-4.6*# Mg-1.6 [**2104-1-7**] 02:54AM BLOOD Albumin-2.7* Calcium-8.1* Phos-4.0 Mg-1.6 [**2104-1-7**] 04:59PM URINE Color-Yellow Appear-Clear Sp [**Last Name (un) **]-1.006 [**2104-1-7**] 04:59PM URINE Blood-SM Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-4* pH-7.0 Leuks-TR [**2104-1-6**] 02:56AM URINE Color-Yellow Appear-Clear Sp [**Last Name (un) **]-1.011 [**2104-1-6**] 02:56AM URINE Blood-TR Nitrite-NEG Protein-NEG Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-4* pH-5.0 Leuks-NEG [**2104-1-6**] 02:56AM URINE RBC-[**6-11**]* WBC-[**3-6**] Bacteri-FEW Yeast-NONE Epi-[**3-6**] RenalEp-[**3-6**] .
Segment IV s/p RFA cystic and solid lesion with mural nodules concerning for tumor recurrence.
[**2104-1-17**] 05:35AM BLOOD WBC-8.9 RBC-2.92* Hgb-9.5* Hct-27.8* MCV-95 MCH-32.4* MCHC-34.1 RDW-15.4 Plt Ct-126* [**2104-1-17**] 05:35AM BLOOD PT-18.7* PTT-38.6* INR(PT)-1.7* [**2104-1-17**] 05:35AM BLOOD Glucose-126* UreaN-27* Creat-1.8* Na-129* K-4.0 Cl-99 HCO3-23 AnGap-11 [**2104-1-17**] 05:35AM BLOOD ALT-33 AST-73* LD(LDH)-232 AlkPhos-137* TotBili-1.0 [**2104-1-17**] 05:35AM BLOOD Albumin-2.6* Calcium-7.8* Phos-3.6 Mg-1.6 [**2104-1-10**] 08:45AM BLOOD calTIBC-294 VitB12-1338* Folate-9.0 Ferritn-219 TRF-226  Brief Hospital Course: 57 year old man w/ history of HCV and HCC s/p RFA in [**8-/2103**], w/ Grade I/II varices, not on nadolol was admitted w/ episode of hematemesis/UGIB [**2-4**] [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] tear, diagnosed on emergent endoscopy.
Patient received 2U of PRBCs and FFP and was transfered from ICU to the floor for further care.
Patient initially presented with a GIB due to [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] tear diagnosed via EGD.
Patient was started on protonix 40 mg [**Hospital1 **] and Nadolol 20mg QD.
He received 2U of PRBCs and HCT nadired at 24, 26 on admission and was 30 after transfusions.
No polypectomy was performed due to agitation by the patient and INR of 1.6.
He will require a repeat colonoscopy for polypectomy and pathology evaluation.
Chronic anemia could not be further characterized and patient had received transfusions.
He will require outpatient evaluation including iron studies, reticulocyte count and vitamin studies.
#) ESLD, HepC cirrhosis/HCC s/p RFA in [**8-9**].
Liver ultrasound showed coarsened liver echotexture, segment IV s/p RFA cystic and solid lesion with mural nodules concerning for tumor recurrence, segment III lesion also raises the possibility of recurrence, persistent small asictes, gallstones, normal portal venous system.
He was started on lactulose and rifaximin.
Due to persistent ecephalopathy and elevated WBC, patient was started on ceftriaxone for possible SBP.
He was started on ampicillin IV on [**1-11**] and ceftriaxone was discontinued.
Due to concern for recurrent bleeding, patient's nadolol was increased to 40mg daily.
His lactulose was titrated to [**3-5**] BMs per day and Rifaximin was continued at 400mg TID.
Urine lytes were intially consistent with intrinsic disease, Na of 105, FeNA > 1%, however eventually showed pre-renal state w/ Na 18, FeNA <1%.
improved after albmuin administration and PRBC transfusions.
With this treatment, patient's LE edema re-accumulated, approximately 1+ at time of discharge with 5kg wt gain over last 4 days of hospitalization.
Patient was restarted on Lasix 40 QD and Spironolactone of 50mg qd at time of discharge.
on methadone 40 mg QAM and 30 mg QPM as outpatient.
Patient was evaluated by physical therapy was deemed to require rehabilitation for further gait and strength training.
was discharged w/ HISS and Lantus 85U QHS.
he was restarted on home Diltiazem CR at 120 QD on HD#5 and Spironolactone at discharge.
Issues requiring follow up: - Completion of ABx for UTI - Titration of diuretics for optimal volume status - Electrolyte monitoring with restarting of diuretics, 2d after discharge - Blood pressure regimen optimization - HCT labs 2d after discharge - MRI abdomen at [**Hospital1 18**] follow up - PCP and Liver Clinic follow up as arranged.
Extremities: right leg external rotation > left at rest; flat solar surfaces, onychomycosis, no ulceration.
Insulin Glargine 100 unit/mL Solution Sig: Eighty Five (85) units Subcutaneous at bedtime.
Methadone 40 mg Tablet, Soluble Sig: One (1) Tablet, Soluble PO QAM (once a day (in the morning)).
Methadone 10 mg Tablet Sig: Three (3) Tablet PO QPM (once a day (in the evening)).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Diltiazem HCl 120 mg Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO DAILY (Daily).
Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO QHS (once a day (at bedtime)) as needed.
Rifaximin 200 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day).
Nadolol 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): Hold for SBP < 90, HR < 60, page house officer if holding.
Ciprofloxacin 250 mg Tablet Sig: Three (3) Tablet PO QMON (every Monday): SBP prophylaxis .
Insulin Lispro 100 unit/mL Solution Sig: One (1) Subcutaneous see sliding scale: see sliding scale.
Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day: Hold for SBP < 90.
Spironolactone 50 mg Tablet Sig: One (1) Tablet PO once a day: Hold for SBP < 100.
Nitrofurantoin Macrocrystal 100 mg Capsule Sig: One (1) Capsule PO every six (6) hours for 2 days.
Discharge Disposition: Extended Care  Facility: [**Hospital3 1186**] - [**Location (un) 538**]  Discharge Diagnosis: Primary: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] Tear with hemorrhage, acute kidney injury, hepatic encephalopathy, urinary tract infection Secondary: Hepatitis C and Hepatocellular Carcinoma, Cirrhosis, Anemia of chronic disease, Esophageal Varices, Hypertension, Diabetes.
You received blood transfusions for this and your blood levels stabilized.
Because of the varices in your esophagus, you were started on a medication called nadolol to prevent bleeding.
Because of this you were started on two medications: lactulose and rifaximin.
In addition, you were found to have a urinary tract infection, which was treated with intravenous antibiotic.
With blood transfusions and intravenous fluids your kidney function recovered.
You were restarted on your diuretics the day of discharge at lower doses, 50mg daily of Spironolactone and Lasix at 40mg daily.
Your medications were adjusted.
Please see list below and only take medications you were prescribed.
For repeat colonoscopy and polypectomy.
